Bacil Pharma reports standalone net loss of Rs 0.01 crore in the September 2026 quarter

Reported sales nil

Net loss of Bacil Pharma reported to Rs 0.01 crore in the quarter ended September 2026 as against net profit of Rs 0.01 crore during the previous quarter ended September 2025. There were no Sales reported in the quarter ended September 2026 and during the previous quarter ended September 2025.

Powered by Capital Market - Live News